Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metronomic Capecitabine With Digoxin for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment

NCT01887288 is registered in ClinicalTrials.gov with Western Regional Medical Center as lead sponsor.

NCT NCT01887288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01887288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metronomic Capecitabine With Digoxin for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
Lead sponsor
Western Regional Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2013
Completion date
November 30, 2015
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer